SBLOF (Shin Nippon Biomedical Laboratories) Marketable Securities: $0.0 Mil (As of Mar. 2026)


SBLOF Shin Nippon Biomedical Laboratories Ltd SBLOF
69 GF Score
Price $9.16
GF Value $13.86
! 5 Warning Signs
View Full Analysis

What is Shin Nippon Biomedical Laboratories Marketable Securities?

Shin Nippon Biomedical Laboratories SBLOF -2.13% 69 Marketable Securities is $0.0 Mil as of Mar. 2026. GuruFocus rates SBLOF with a GF Score™ of 69/100 and a GF Value™ of $13.86. The stock has 5 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Shin Nippon Biomedical Laboratories's Marketable Securities for the quarter that ended in Mar. 2026 was $0.0 Mil.

Shin Nippon Biomedical Laboratories's annual Marketable Securities declined from Mar. 2024 ($2.2 Mil) to Mar. 2025 ($0.0 Mil) but then stayed the same from Mar. 2025 ($0.0 Mil) to Mar. 2026 ($0.0 Mil).

Shin Nippon Biomedical Laboratories  (OTCPK:SBLOF) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Shin Nippon Biomedical Laboratories Marketable Securities Related Terms

Shin Nippon Biomedical Laboratories Marketable Securities Historical Data

* Premium members only.

The historical data trend for Shin Nippon Biomedical Laboratories's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shin Nippon Biomedical Laboratories Marketable Securities Chart

Shin Nippon Biomedical Laboratories Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.10 0.00 2.25 0.00 0.00

Shin Nippon Biomedical Laboratories Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
SBLOF
69GF Score
Shin Nippon Biomedical Laboratories Ltd SBLOF
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shin Nippon Biomedical Laboratories Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of $0.0 Mil mean?
Shin Nippon Biomedical Laboratories (SBLOF) has a Marketable Securities of $0.0 Mil as of Mar. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Shin Nippon Biomedical Laboratories and its competitors.
Is Shin Nippon Biomedical Laboratories' Marketable Securities too high?
Shin Nippon Biomedical Laboratories' current Marketable Securities is $0.0 Mil. Overall, Shin Nippon Biomedical Laboratories has a GF Score™ of 69/100, reflecting its overall financial health beyond just this single metric.
How does Shin Nippon Biomedical Laboratories' Marketable Securities compare to TMO and DHR?
Shin Nippon Biomedical Laboratories' Marketable Securities of $0.0 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Medical Diagnostics & Research company?
A good Marketable Securities depends on the Medical Diagnostics & Research industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Shin Nippon Biomedical Laboratories and its competitors. Shin Nippon Biomedical Laboratories's current Marketable Securities is $0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shin Nippon Biomedical Laboratories stock overvalued right now?
Shin Nippon Biomedical Laboratories (SBLOF) has a current Marketable Securities of $0.0 Mil. The stock's GF Value™ is $13.86, compared to a current price of $9.16 — trading 33.9% below its estimated fair value. The current Marketable Securities is $0.0 Mil. Shin Nippon Biomedical Laboratories' overall GF Score™ is 69/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Shin Nippon Biomedical Laboratories (SBLOF), the current Marketable Securities is $0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shin Nippon Biomedical Laboratories (SBLOF) Overvalued in 2026?

Based on GuruFocus' analysis, Shin Nippon Biomedical Laboratories stock appears to be undervalued. The current stock price of $9.16 is trading 33.9% below its estimated GF Value™ of $13.86.

Key valuation signals for SBLOF:

  • Marketable Securities: $0.0 Mil
  • GF Value™: $13.86 vs. price of $9.16 (33.9% below fair value)
  • GF Score™: 69/100 with 5 warning signs

No single metric tells the full story. See the SBLOF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Shin Nippon Biomedical Laboratories Business Description

Other Exchanges 2395:JapanYB3:Germany
Address 8-1 Akashi-cho, Tokyo, JPN
Shin Nippon Biomedical Laboratories Ltd provides pre-clinical testing services in the pharmaceutical industry in Japan. The company provides a range of services such as pre-clinical and analysis studies, contracted clinical trials, SMO, CRO, translational research and cancer treatment.
69GF Score

Get the complete analysis for SBLOF

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$9.16
Price
$13.86
GF Value